VR

Vijayabhaskar Reddy Kandula

Active Director Director DIN 08702732
DIN 08702732 First appointment Feb 2020 Primary industry Pharma
Unlock full profile Investments · shareholding · contact details
Current companies 2 active board seats
Total affiliations 2 Since Feb 2020
Shareholding value •••• Premium profile

About Vijayabhaskar Reddy Kandula

Data last updated:

Vijayabhaskar Reddy Kandula is a Director at Medtherapy Biotechnology (India) Private Limited (since 2020) and Director at Global Center For Gene Therapies Foundation (since 2025). The companies operate in Pharma and Professional Services. The largest current company by reported revenue is Medtherapy Biotechnology (India) Private Limited at ₹5.18 Cr (FY 2025).

DIN 08702732
Primary Designation Director
Industry Pharma
First Appointment 18 Feb 2020
Oldest Company Age 6 yrs
Largest company Medtherapy Biotechnology (India) Private Limited · ₹5.18 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director18 Feb 20202020₹5.18 Cr (FY 2025)Active
Director13 Jan 20252025Active

Directorship timeline

Open interactive timeline →
Global Center For Gene Therapies Foundation
Medtherapy Biotechnology (India) Private Limited
Premium access

Shareholding and investment profile for Vijayabhaskar Reddy Kandula

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Vijayabhaskar Reddy Kandula

Vijayabhaskar Reddy Kandula currently holds 2 directorships: Medtherapy Biotechnology (India) Private Limited (Director, since 18 Feb 2020, revenue ₹5.18 Cr (FY 2025)); Global Center For Gene Therapies Foundation (Director, since 13 Jan 2025).

Vijayabhaskar Reddy Kandula was first appointed on 18 Feb 2020 as Director at Medtherapy Biotechnology (India) Private Limited. The most recent appointment on record is 13 Jan 2025 at Global Center For Gene Therapies Foundation.

The current boards of Vijayabhaskar Reddy Kandula's companies include Bikash Kumar Verma (Medtherapy Biotechnology (India) Private Limited), Sanjay Kumar Singh (Global Center For Gene Therapies Foundation).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available